Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Atea Pharmaceuticals, Inc.
Market Cap
$410.54M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$408.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$406.47M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$415.93M
Operating Margin
-61.09%
TTM Avg
-74.66%
3Y Avg
-94.75%
5Y Avg
-94.75%
Market Cap
$416.68M
Operating Margin
-111.51%
TTM Avg
-90.32%
3Y Avg
-56.08%
5Y Avg
-435.91%
Market Cap
$428.16M
Operating Margin
-245.15%
TTM Avg
-511.19%
3Y Avg
-596.30%
5Y Avg
-548.32%
Market Cap
$447.43M
Operating Margin
0.00%
TTM Avg
-95.56%
3Y Avg
-362.67%
5Y Avg
-2402.18%
Market Cap
$373.40M
Operating Margin
-31.98%
TTM Avg
-34.62%
3Y Avg
-233.89%
5Y Avg
-229.53%
Market Cap
$450.64M
Operating Margin
-11.75%
TTM Avg
-88.01%
3Y Avg
-269.63%
5Y Avg
-547.01%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $410.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -58.53% | -50.96% | -52.76% | -52.76% |
| Carlsmed, Inc. (CARL)vs › | $415.93M | -61.09% | -74.66% | -94.75% | -94.75% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | -111.51% | -90.32% | -56.08% | -435.91% |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -245.15% | -511.19% | -596.30% | -548.32% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | 0.00% | -95.56% | -362.67% | -2402.18% |
| Canopy Growth Corporation (CGC)vs › | $373.40M | -31.98% | -34.62% | -233.89% | -229.53% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | -11.75% | -88.01% | -269.63% | -547.01% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -14.22% | -4.51% | -387.94% | -2012.06% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 63.06% |
| 2021-09-30 | -67.50% |
| 2021-06-30 | 14.38% |
| 2021-03-31 | 46.46% |
| 2020-12-31 | 42.45% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
